Back
OncoCyte Vs. Insmed Industry Stock Comparison
Sell
37
OCX
OncoCyte
Last Price:
2.85
Seasonality Move:
-0.85%
Buy
61
INSM
Insmed
Last Price:
72.22
Seasonality Move:
4.27%
Sell
37
OncoCyte (OCX)
is a Sell
Is OncoCyte a Buy, Sell or Hold?
- The current OncoCyte [OCX] share price is $2.98. The Score for OCX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- OCX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $71.40. The Score for INSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INSM Stock Price Chart
OCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 47.23 | Sell |
| Chaikin Money Flow: | -27542 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.94 - 3.18) | Sell |
| Bollinger Bands (100): | (2.8 - 3.18) | Sell |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 42.48 | Sell |
| Chaikin Money Flow: | -861581 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.87 - 74.63) | Sell |
| Bollinger Bands (100): | (50.82 - 81.14) | Buy |
OCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.93 | Buy |
| 20-day SMA: | 3.05 | Sell |
| 50-day SMA: | 3.08 | Sell |
| 200-day SMA: | 2.97 | Buy |
| 8-day EMA: | 2.97 | Buy |
| 20-day EMA: | 3.02 | Sell |
| 50-day EMA: | 3.04 | Sell |
| 200-day EMA: | 3.31 | Sell |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.62 | Sell |
| 20-day SMA: | 72.85 | Sell |
| 50-day SMA: | 74.03 | Sell |
| 200-day SMA: | 46.81 | Buy |
| 8-day EMA: | 72.6 | Sell |
| 20-day EMA: | 73.12 | Sell |
| 50-day EMA: | 71.91 | Sell |
| 200-day EMA: | 52.94 | Buy |
OncoCyte Earnings Growth & OCX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $1.08 per share.
OncoCyte Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||